We conducted targeted sequencing of 151 disease-associated genes that have been implicated in studies of a wide range of cancers in 22 p16+ (HPV+), 4 p16- (HPV-), and one p16-unknown (HPV unknown status) tumor samples using Agilent’s ClearSeq Comprehensive Cancer panel. Here, CDKN2A is linked to neoplasm.